Skip to main content
. 2015 Oct 8;13:259. doi: 10.1186/s12916-015-0489-y

Table 2.

Relationships between s-RNY1-5p and classical cardiovascular risk factors in controls and cases

Controls (n = 514) Cases (n = 263)
Age (years) −0.07 (0.10) −0.09 (0.14)
School (years of schooling) 0.01 (0.88) −0.05 (0.39)
Alcohol (g/day) −0.12 (0.008) −0.04 (0.50)
Tobacco consumption number (pack/year) 0.04 (0.50) 0.14 (0.03)
Levels of physical activity −0.01 (0.88) −0.04 (0.50)
Waist (cm) −0.09 (0.04) −0.02 (0.80)
Body mass index (kg/m2) −0.07 (0.14) −0.03 (0.63)
Total cholesterol (g/L) 0.07 (0.11) 0.11 (0.09)
HDL-cholesterol (g/L) −0.03 (0.53) −0.02 (0.82)
LDL-cholesterol (g/L) 0.09 (0.05) 0.12 (0.06)
Triglyceride (g/L) 0.03 (0.52) 0.01 (0.90)
ApoA-I (g/L) −0.09 (0.04) −0.08 (0.17)
ApoB (g/L) 0.18 (<0.001) 0.18 (0.003)
Lipoprotein (a) (g/L) 0.04 (0.39) 0.07 (0.24)
hs-CRP (mg/L) 0.16 (<0.001) 0.14 (0.03)
Gamma glutamyl transferase (IU/L) 0.04 (0.41) 0.11 (0.09)
Fasting glucose (mmol/L) 0.06 (0.22) −0.04 (0.54)
Serum insulin (UI/L) −0.07 (0.14) −0.02 (0.81)
HOMA-IR −0.05 (0.24) −0.05 (0.46)
Systolic blood pressure (mmHg) −0.01 (0.74) −0.08 (0.19)
Resting heart rate (beat/mn) 0.04 (0.42) 0.03 (0.64)

Spearman rank correlation coefficients (P value)

ApoA-I, Apolipoprotein A-I; ApoB, Apolipoprotein B; hs-CRP, High sensitive C-reactive protein; HOMA-IR, Homeostatic model assessment-insulin resistance